Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE‐TPA): A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Study - Concepedia

Concepedia

Publication | Open Access

Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE‐TPA): A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Study

DOI Full Paper Access

34

Citations

28

References

2019

Year

Jong S. Kim, Kyung Bok Lee, Jong‐Ho Park, Sang Min Sung, Kyungmi Oh, Eung‐Gyu Kim, Dae‐Il Chang, Yang‐Ha Hwang, Eun‐Jae Lee, Won‐Ki Kim,

Annals of Neurology

Abstract

Intravenous otaplimastat adjunctive therapy in patients receiving rtPA is feasible and generally safe. The functional efficacy of otaplimastat needs to be investigated with further large trials. ANN NEUROL 2020;87:233-245.

References

	Year	Citations

Page 1